NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Sees Large Drop in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a significant drop in short interest in February. As of February 15th, there was short interest totalling 1,200 shares, a drop of 89.1% from the January 31st total of 11,000 shares. Based on an average trading volume of 23,700 shares, the days-to-cover ratio is currently 0.1 days.

NRx Pharmaceuticals Stock Down 5.9 %

Shares of NRXPW stock traded down $0.01 during mid-day trading on Friday, reaching $0.10. 170,913 shares of the company were exchanged, compared to its average volume of 39,206. NRx Pharmaceuticals has a fifty-two week low of $0.04 and a fifty-two week high of $0.50. The business’s 50 day simple moving average is $0.19 and its 200 day simple moving average is $0.11.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.